> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-132/
- Published: 2017-04-23T12:00:00.000Z
- Updated: 2026-09-14T22:19:08.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5138522

[**Comments Sought on FDA’s Focus Group Use**](https://www.fdaweb.com/comments-sought-on-fdas-focus-group-use/) 04/21/2017  
*Federal Register* notice: FDA seeks comments on an information collection on “Focus Groups as Used by the Food and Drug Administration (all FDA- regulated products).”

[**Comments Sought on Dietary Supplement Recordkeeping**](https://www.fdaweb.com/comments-sought-on-dietary-supplement-recordkeeping/) 04/20/2017  
*Federal Register* notice: FDA asks for comments on an information collection: “Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements — 21 CFR Part 111.”

[**Imaging Drugs Panel to Review NX Development Imaging Agent**](https://www.fdaweb.com/imaging-drugs-panel-to-review-nx-development-imaging-agent/) 04/19/2017  
*Federal Register* notice: FDA announces a 5/10 Medical Imaging Drugs Advisory Committee meeting that will discuss a NX Development Corp. NDA for a new imaging agent.

[**Oncologic Panel to Review to NDAs in May**](https://www.fdaweb.com/oncologic-panel-to-review-to-ndas-in-may/) 04/19/2017  
*Federal Register* notice: FDA announces a 5/24 Oncologic Drugs Advisory Committee meeting that will review two NDAs.

[**Hospira Epogen/Procrit Biosimilar Heads to Panel Meeting**](https://www.fdaweb.com/hospira-epogen-procrit-biosimilar-heads-to-panel-meeting/) 04/19/2017  
*Federal Register* notice: FDA announces a 5/25 Oncologic Drugs Advisory Committee meeting that will discuss a Hospira BLA for a proposed biosimilar product referencing Amgen’s Epogen/Procrit (epoetin alfa).

[**Public Workshop on Safe Opioid Prescribing**](https://www.fdaweb.com/public-workshop-on-safe-opioid-prescribing/) 04/18/2017  
*Federal Register* notice: FDA announces a 5/9-10 workshop to obtain input on issues and challenges associated with federal efforts to support training on pain management with opioids.